A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients
- 1 February 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 25 (2) , 346-351
- https://doi.org/10.1097/00003246-199702000-00025
Abstract
To assess endoscopically the effect of prophylactic short-term ranitidine treatment in the prevention of stress-induced gastric lesions in neonatal intensive care unit (ICU) patients. Prospective, randomized study. Department of Neonatal Intensive Care, University Hospital of Tampere. Fifty-three infants were enrolled in a randomized, controlled study. Forty-eight (90%) of these patients underwent endoscopic examination and were evaluated. A histamine-2-receptor blocker, ranitidine, was given prophylactically after birth for 4 days to infants mechanically ventilated and treated in the neonatal ICU. The gastric mucosa was both visually and histologically evaluated after 3 to 6 days, and the outcome of the infants was registered. In the 23 infants prophylactically treated with ranitidine, the gastric mucosa was visually classified as normal in 14 (61%) infants as compared with five (20%) of 25 controls (p < .004). Histologic lesions showed parallel results (57% vs. 16%, p < .004). Eight gastric ulcers were diagnosed endoscopically in the control group vs. none in the treatment group. The ulcers were all clinically "silent" at the time of endoscopy. According to logistic regression modeling, the decreased risk for gastric mucosal lesions in infants receiving prophylactic ranitidine was 0.03 (95% confidence interval 0.003 to 0.178). Surfactant treatment for infant respiratory distress syndrome also decreased the risk for stress-induced gastric mucosal lesions (odds ratio 0.083; 95% confidence interval 0.009 to 0.788), whereas other variables (birth weight, gestational age, Apgar scores, cord blood pH, and duration of intubation) had no significant effect. No side effects could be attributed to the ranitidine treatment. We conclude that short-term prophylactic ranitidine treatment prevents gastric mucosal lesions in newborn infants under stress.Keywords
This publication has 29 references indexed in Scilit:
- Risk Factors for Gastrointestinal Bleeding in Critically Ill PatientsNew England Journal of Medicine, 1994
- Stress ulcer prophylaxisCritical Care Medicine, 1993
- Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patientsCritical Care Medicine, 1992
- Frequency of upper gastrointestinal bleeding in a pediatric intensive care unitCritical Care Medicine, 1992
- The Clinical Significance and Pathophysiology of Stress-Related Gastric Mucosal HemorrhageJournal of Clinical Gastroenterology, 1991
- Stress ulcer prophylaxis in the critically III: A meta-analysisThe American Journal of Medicine, 1991
- Prophylactic Therapy for Stress Ulcer Bleeding: A ReappraisalAnnals of Internal Medicine, 1987
- Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: Prophylaxis trial with cimetidineThe Journal of Pediatrics, 1986
- Perforated Stress Ulcer in InfantsAnnals of Surgery, 1979
- Acute Gastroduodenal Disease after Thermal InjuryNew England Journal of Medicine, 1974